Controlling tumor progression and recurrence in mice through combined treatment with a PD-L1 inhibitor and a designer Salmonella strain that delivers GM-CSF
Acta Pharm. Sin. B, Available online 10 July 2024 | https://doi.org/10.1016/j.apsb.2024.07.011
Phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06)
J. Immunother. Cancer, Mar 13 2024, 12 (3) e008638 | https://doi.org/10.1136/jitc-2023-008638